News

Lupin Receives European Commission Approval for Biosimilar Ranibizumab

Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds and inhibits vascular endothelial growth factor A.

Feb 23, 2026

By : Team ABLE

Karnataka BioEconomy Report 2025 Released

Karnataka contributes one-fifth to the national bioeconomy

Feb 21, 2026

By : Team ABLE

DRL enters Hormone Replacement Therapy with acquisition of Progynova and Cyclo- Progynova in India from UK company

Progynova (estradiol valerate) and Cyclo-Progynova (estradiol valerate and norgestrel), commonly used for menopause management.

Feb 18, 2026

By : Team ABLE

Lupin Q3 FY2026 Results

Financial Highlights

Feb 12, 2026

By : Team ABLE

Government announces Rs 10000 cr BioPharma Shakti program in Union Budget 2026 to 2027

The announcement was made during the Budget on February 1, 2026.

Feb 02, 2026

By : Team ABLE